e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD
Samantha J. Thulborn, Jennifer L. Cane, Clare Connolly, Catherine Borg, Kelly L. Moffitt, David Ribeiro, Charlene Robb, Richard E.K. Russell, Mona Bafadhel
Source:
Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Samantha J. Thulborn, Jennifer L. Cane, Clare Connolly, Catherine Borg, Kelly L. Moffitt, David Ribeiro, Charlene Robb, Richard E.K. Russell, Mona Bafadhel. Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD. Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
An improved assay for detection of sputum periostin in patients with asthma
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
Evaluation of novel sputum processing methods and sensitive detection techniques in allergic asthmatics
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009
Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
The sensitivity and specificity of diagnostic methods in baker’s asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 368s
Year: 2004
The sensitivity and specificity of specific IgE in diagnosing asthma
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
Sputum induction in asthmatic children: safety in children and feasibility of new methods of monitoring inflammation in sputum samples
Source: Eur Respir J 2006; 28: Suppl. 50, 259s
Year: 2006
Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Accuracy of the multidisciplinary diagnosis of COVID-19 in patients with negative nasopharyngeal swabs RT-PCR, evaluated using BAL as diagnostic gold standard.
Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy
Year: 2021
A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay
Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018
Year: 2019
The impact of different reference standards when estimating the accuracy of tests for diagnosing asthma
Source: International Congress 2018 – Primary care management of asthma
Year: 2018
Active detection of COPD, methods and results
Source: Annual Congress 2009 - PG6 Core Curriculum Postgraduate Course: How to reduce the burden of COPD
Year: 2009
Cross shift measurements of lung function have poor sensitivity and specificity in the diagnosis of occupational asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 244s
Year: 2006
Development of a novel immunoassay for the measurement of active plasmin in patients with IPF
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Compatibility of a novel filter paper-based bio-safe sputum transport kit with line probe assay for diagnosing drug-resistant tuberculosis: a single-site evaluation study
Source: ERJ Open Res, 7 (3) 00137-2021; 10.1183/23120541.00137-2021
Year: 2021
LSC - 2019 - Validating immunoproteasome activity as a potential biomarker in non-invasive samples from COPD patients
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Simultaneous analysis of sputum and serum biomarkers in adult asthma
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Early detection of lung cancer in patients with COPD by eNose technology
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Comparison between the diagnostic yield of tissue Xpert MTB/Rif assay and culture in pleural tuberculosis patients.
Source: International Congress 2019 – Interventional pulmonology: a mixture of spices
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept